1. Home
  2. TOVX vs GIPR Comparison

TOVX vs GIPR Comparison

Compare TOVX & GIPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOVX
  • GIPR
  • Stock Information
  • Founded
  • TOVX 2001
  • GIPR 2015
  • Country
  • TOVX United States
  • GIPR United States
  • Employees
  • TOVX N/A
  • GIPR N/A
  • Industry
  • TOVX Biotechnology: Pharmaceutical Preparations
  • GIPR Real Estate Investment Trusts
  • Sector
  • TOVX Health Care
  • GIPR Real Estate
  • Exchange
  • TOVX Nasdaq
  • GIPR Nasdaq
  • Market Cap
  • TOVX 4.5M
  • GIPR 5.1M
  • IPO Year
  • TOVX 2006
  • GIPR 2021
  • Fundamental
  • Price
  • TOVX $0.41
  • GIPR $1.11
  • Analyst Decision
  • TOVX Hold
  • GIPR
  • Analyst Count
  • TOVX 1
  • GIPR 0
  • Target Price
  • TOVX N/A
  • GIPR N/A
  • AVG Volume (30 Days)
  • TOVX 1.0M
  • GIPR 358.4K
  • Earning Date
  • TOVX 11-11-2025
  • GIPR 11-14-2025
  • Dividend Yield
  • TOVX N/A
  • GIPR N/A
  • EPS Growth
  • TOVX N/A
  • GIPR N/A
  • EPS
  • TOVX N/A
  • GIPR N/A
  • Revenue
  • TOVX N/A
  • GIPR $9,884,093.00
  • Revenue This Year
  • TOVX N/A
  • GIPR N/A
  • Revenue Next Year
  • TOVX N/A
  • GIPR N/A
  • P/E Ratio
  • TOVX N/A
  • GIPR N/A
  • Revenue Growth
  • TOVX N/A
  • GIPR 2.33
  • 52 Week Low
  • TOVX $0.37
  • GIPR $0.78
  • 52 Week High
  • TOVX $4.29
  • GIPR $2.44
  • Technical
  • Relative Strength Index (RSI)
  • TOVX 46.90
  • GIPR 58.71
  • Support Level
  • TOVX $0.38
  • GIPR $0.88
  • Resistance Level
  • TOVX $0.45
  • GIPR $1.14
  • Average True Range (ATR)
  • TOVX 0.02
  • GIPR 0.10
  • MACD
  • TOVX 0.00
  • GIPR 0.03
  • Stochastic Oscillator
  • TOVX 46.71
  • GIPR 75.00

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

About GIPR Generation Income Properties Inc.

Generation Income Properties Inc is an internally managed real estate investment company focused on acquiring and managing income-producing retail, office and industrial properties net leased to high-quality tenants in markets throughout the United States. Its key source of revenue is the rental income. The company holds properties in Alabama, Arizona, Colorado, the District of Columbia, Florida, Illinois, North Carolina and Virginia.

Share on Social Networks: